BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv Funct Mater 2021;31:2100088. [DOI: 10.1002/adfm.202100088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Liew SS, Wang J, Pu K. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines. Adv Mater 2021;:e2103790. [PMID: 34651344 DOI: 10.1002/adma.202103790] [Reference Citation Analysis]
2 Sun J, Ogunnaike EA, Jiang X, Chen Z. Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA. J Mater Chem B 2021. [PMID: 34382987 DOI: 10.1039/d1tb01379c] [Reference Citation Analysis]
3 Wang J, Zhang Y, Pi J, Xing D, Wang C. Localized delivery of immunotherapeutics: A rising trend in the field. J Control Release 2021;340:149-67. [PMID: 34699871 DOI: 10.1016/j.jconrel.2021.10.013] [Reference Citation Analysis]
4 Liu N, Zhu L, Li Z, Liu W, Sun M, Zhou Z. In situ self-assembled peptide nanofibers for cancer theranostics. Biomater Sci 2021;9:5427-36. [PMID: 34319316 DOI: 10.1039/d1bm00782c] [Reference Citation Analysis]
5 Lai V, Neshat SY, Rakoski A, Pitingolo J, Doloff JC. Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity. Adv Drug Deliv Rev 2021;:113920. [PMID: 34384826 DOI: 10.1016/j.addr.2021.113920] [Reference Citation Analysis]